Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Detecting an Early Response to Donepezil With Measures of Visual Attention

Trial Profile

Detecting an Early Response to Donepezil With Measures of Visual Attention

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Oct 2019 Planned End Date changed from 31 Jul 2019 to 31 Dec 2019.
    • 20 Nov 2018 Planned End Date changed from 31 Dec 2017 to 31 Jul 2019.
    • 10 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top